4th Annual Pharmaceutical Reimbursement & Market Access Conference
Philadelphia, USA (Srpen, 27-28, 2012)
Throughout the industry, Pharmaceutical & Biotechnology manufacturers are facing increasing pressure from all stakeholders related to the coverage and reimbursement of new and existing therapies. Although the legality of recent healthcare reform in the US has been taken into question, there is no doubt that the government, payers and consumers will continue to pressure the pharmaceutical industry to lower costs, regardless of the outcome of reform. As such, the industry needs to be prepared for every eventuality, by compiling and presenting the most compelling cases for the reimbursement of their products, through precise and thorough evidence development and presentation. During the 4th Annual Pharmaceutical Reimbursement & Market Access Conference, presenters and attendees will have an opportunity to discuss and debate the many challenges and changes that have occurred over the course of the past 12-18 months, and also forecast the future of this dynamic industry.
Though the concept of evidence development and dossiers is not a new area for pharmaceutical corporations, today's environment requires these documents to contain more information than ever before, and requires that data be collected in an extremely rigorous manner. Evidence development and use will be a primary theme of the 2012 annual program, allowing organizations an opportunity to hear from various stakeholders, from government representatives to private payers, on the evidence they feel is most applicable and compelling when making coverage decisions. The increasing relevance and utilization of health technology assessments will also be discussed, providing a global theme to the program content.
As with all Q1 conference programs, the focus of the event will not only include educational program content delivered by experienced executives and multiple stakeholders but will also include formal and informal networking opportunities that are so critical to the success of this industry. Through a carefully blended program including case studies, panel discussions and networking opportunities, the 4th Annual Pharmaceutical Reimbursement & Market Access conference will once again be a must attend program.
